Literature DB >> 29736874

A bargaining approach for resolving the tradeoff between beneficial and harmful drug responses.

Andrey Garnaev1, Wade Trappe2.   

Abstract

In medical treatments, a fundamental dilemma often arises: on the one hand, an increase in a drug's dose could lead to a stronger, therapeutic treatment response, but on the other hand this could also lead to increased toxicity risks. In this paper, we propose to solve this dilemma using a Nash bargaining approach. To do so, we reformulate the tradeoff problem in an equivalent form as a dilemma between a drug's beneficial response and the drug's safety, where the dilemma then becomes a two-objective problem with safety and response as the objectives. Using a general receptor response model, we show that the set of all feasible outcomes associated with a drug's treatment is characterized as a convex set, which allows the dilemma to be solved as a bargaining problem between the two objectives. The Nash bargaining solution (NBS) is found in closed form, and interesting properties associated with the solution are presented. In particular, it is shown that one can interpret the NBS as corresponding to a treatment giving the maximal expected safe treatment response associated with the drug. Moreover, the condition when the NBS coincides with the maxmin solution for the two objectives is derived. Two approaches to control the NBS solution are then presented: first, by means of assigning bargaining powers to objectives; second, by means of assigning an upper-bound on the drug's dosage. The obtained NBS are compared with the dosage returning maximal drug response efficiency.

Entities:  

Keywords:  Nash bargaining; Toxic risk; Treatment response

Mesh:

Substances:

Year:  2018        PMID: 29736874     DOI: 10.1007/s00285-018-1242-x

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  7 in total

1.  Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens.

Authors:  Roland R Regoes; Camilla Wiuff; Renata M Zappala; Kim N Garner; Fernando Baquero; Bruce R Levin
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations.

Authors:  Peter F Thall; John D Cook; Elihu H Estey
Journal:  J Biopharm Stat       Date:  2006       Impact factor: 1.051

3.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

4.  Dose-finding based on efficacy-toxicity trade-offs.

Authors:  Peter F Thall; John D Cook
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

5.  Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli.

Authors:  Kevin B Wood; Philippe Cluzel
Journal:  BMC Syst Biol       Date:  2012-05-25

6.  A new modeling approach to the effect of antimicrobial agents on heterogeneous microbial populations.

Authors:  Michael Nikolaou; Vincent H Tam
Journal:  J Math Biol       Date:  2005-09-29       Impact factor: 2.164

7.  A streamlined search technology for identification of synergistic drug combinations.

Authors:  Andrea Weiss; Robert H Berndsen; Xianting Ding; Chih-Ming Ho; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Patrycja Nowak-Sliwinska
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.